Patents by Inventor Artem Cherkasov

Artem Cherkasov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer
    Patent number: 11878961
    Abstract: Procedures for inhibiting hormone receptor activation include administering to a subject in need of hormone receptor inhibition a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions. Procedures for treating prostate cancer or breast cancer include administering to a subject having prostate cancer or breast cancer a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: January 23, 2024
    Assignees: Board of Regents, The University of Texas System, The University of British Columbia
    Inventors: Marc Cox, Artem Cherkasov, Fuqiang Ban
  • Next Generation FKBP52 Targeting Drugs for the Treatment of Prostate and Breast Cancer
    Publication number: 20230234930
    Abstract: Procedures for inhibiting hormone receptor activation include administering to a subject in need of hormone receptor inhibition a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions. Procedures for treating prostate cancer or breast cancer include administering to a subject having prostate cancer or breast cancer a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions.
    Type: Application
    Filed: March 27, 2023
    Publication date: July 27, 2023
    Inventors: Marc Cox, Artem Cherkasov, Fuqiang Ban
  • Next Generation FKBP52 Targeting Drugs for the Treatment of Prostate and Breast Cancer
    Publication number: 20210230125
    Abstract: Procedures for inhibiting hormone receptor activation include administering to a subject in need of hormone receptor inhibition a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions. Procedures for treating prostate cancer or breast cancer include administering to a subject having prostate cancer or breast cancer a compound having a chemical structure of a molecule that, when docked in the PPIase pocket, could disrupt proline-rich loop conformation and interactions.
    Type: Application
    Filed: January 20, 2021
    Publication date: July 29, 2021
    Inventors: Marc Cox, Artem Cherkasov, Fuqiang Ban
  • Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
    Patent number: 10682339
    Abstract: Embodiments of the current invention include methods and compositions for regulating the activity of hormone receptors.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: June 16, 2020
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Marc Cox, Artem Cherkasov
  • PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME
    Publication number: 20190269658
    Abstract: Embodiments of the current invention include methods and compositions for regulating the activity of hormone receptors.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 5, 2019
    Applicants: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Marc COX, Artem Cherkasov
  • Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
    Patent number: 10322113
    Abstract: Embodiments of the current invention include methods and compositions for regulating the activity of hormone receptors.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 18, 2019
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Marc Cox, Artem Cherkasov
  • PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME
    Publication number: 20170231964
    Abstract: Embodiments of the current invention include methods and compositions for regulating the activity of hormone receptors.
    Type: Application
    Filed: August 20, 2015
    Publication date: August 17, 2017
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SY STEM
    Inventors: Marc COX, Rachid SKOUTA, Artem CHERKASOV
  • Small cationic antimicrobial peptides
    Patent number: 9707282
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: July 18, 2017
    Assignee: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Robert E. W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
  • SMALL CATIONIC ANTIMICROBIAL PEPTIDES
    Publication number: 20150315240
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Application
    Filed: April 10, 2015
    Publication date: November 5, 2015
    Inventors: Robert E.W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
  • Small cationic antimicrobial peptides
    Patent number: 9017656
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: April 28, 2015
    Assignee: The University of British Columbia
    Inventors: Robert E. W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
  • Small Cationic Antimicrobial Peptides
    Publication number: 20130266597
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Application
    Filed: December 21, 2012
    Publication date: October 10, 2013
    Inventors: Robert E.W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
  • Small cationic antimicrobial peptides
    Patent number: 8343475
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: January 1, 2013
    Assignee: The University of British Columbia
    Inventors: Robert E. W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
  • Small Cationic Antimicrobial Peptides
    Publication number: 20110236429
    Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
    Type: Application
    Filed: August 21, 2007
    Publication date: September 29, 2011
    Inventors: Robert E. W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell